Aegis is a hydrophilic foam disc impregnated with chlorhexidine gluconate (CHG) that supports clinical best practices and professional guidelines for reducing catheter-related bloodstream infections (CRBSI) and central line-associated bloodstream infections (CLABSI).2,3,6,7 It absorbs exudate and inhibits or kills microorganisms on the dressing’s surface.7
Experience the advantages of Aegis
Absorbs up to 8x its weight in fluid with no distortion8
Fast kill rate
CHG begins killing bacteria within 2 hours7
Provides 360° protection around the insertion site
Sustains progressive “kill” over 7 days7
Indications for use*
Aegis is a CHG-impregnated foam dressing that absorbs exudate and covers the peri-wound area of a wound caused by vascular and non-vascular percutaneous medical devices, such as:
|Size||3/4″ disc (1.9 cm), 1.5 mm Hole||1″ (2.5 cm), 4 mm Hole||1″ disc (2.5 cm), 7 mm Hole|
|French size range||<6Fr||6-12Fr||13-20Fr|
|CHG content||52.5 mg||92 mg||86.8 mg|
|Where to use||
|Pkg.||10/bx, 4 bx/cs||10/bx, 4 bx/cs||10/bx, 4 bx/cs|
Fast kill rate
The CHG present in the dressing acts quickly, demonstrating a 4 log reduction in bacteria on the dressing’s surface within 2 hours.7
The dressing’s two-layer foam absorbs up to eight times its weight in fluid with no distortion.8
Aegis product post fluid absorption
Leading competitor product post fluid absorption
- Hadaway LC. 5 Steps to Preventing Catheter-Related Bloodstream Infections. LPN2009. 2006;2(5):50-55. Available at: http://www.nursingcenter.com/ journalarticle?Article_ID=674810. Accessed December 21, 2016.
- Association for Professionals in Infection Control and Epidemiology. Guide to Preventing Central Line-Associated Bloodstream Infections. Washington, DC; APIC Implementation Guides, December 2015. Available at: http://www.apic.org/Professional-Practice/Implementationguides# Preventing. Accessed December 21, 2016.
- The Joint Commission. Preventing Central Line-Associated Bloodstream Infections: A Global Perspective. Oak Brook, IL: Joint Commission Resources, May 2012. Available at: https://www.jointcommission.org/assets/1/18/CLABSI_Monograph.pdf. Accessed December 21, 2016.
- Gahlot R, Nigam C, Kumar V, Yadav G, Anupurba S. Catheter-related bloodstream infections. International Journal of Critical Illness and Injury Science. 2014;4(2):162-167. Available at: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4093967/. Accessed June 6, 2017.
- Zimlichman E, Henderson D, Tamir O, et al. Health Care-Associated Infections: A Meta-Analysis of Costs and Financial Impact on the U.S. Health Care System. JAMA Intern Med. 2013;173(22):2039-2046. Available at: http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1733452. Accessed November 18, 2016.
- Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. O’Grady NP, Alexander M, Burns LA, et al. Centers for Disease Control and Prevention website. Available at: http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html. Accessed November 18, 2016.
- Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O’Grady NP, Pettis AM, Rupp ME, Sandora T, Maragakis LL, Yokoe DS. Strategies to Prevent Central Line-Associated Bloodstream Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology, Vol. 35, No. 7 (July 2014), pp. 753-771. Available at http://www.jstor.org/stable/10.1086/676533. Accessed November 18, 2016.
- Data available upon request